image description

Tag: hydroxychloroquine

COVID-19 Frequently Asked Questions: What You Should Know

Updated April 3, 2020 The first priority of the Lupus Research Alliance is the health of our lupus community.  We have been consulting with health care authorities and monitoring the situation created by the spread of COVID-19. Please note that every lupus patient is different. If you have specific questions about your condition and/or any […] Read More

CVS Preserving Plaquenil Supply for Patients Taking It

March 26, 2020 CVS put out the following statement yesterday assuring its clients that the company is protecting a supply for people already taking hydroxychloroquine. CVS Health helping protect supply of medicines potentially useful for COVID-19 treatment CVS Caremark, the pharmacy benefit management business of CVS Health, is working with clients to implement new measures […] Read More

Actions from Pharmaceutical Companies to Preserve Hydroxychloroquine (Plaquenil) Supply

March 30, 2020 The rheumatology community has been in discussions with the U.S. Food and Drug Administration and many pharmaceutical companies about the potential shortage of hydroxychloroquine (brand name Plaquenil) in the COVID-19 epidemic, and we are seeing much progress to increase its production and availability. The LRA especially thanks Sandoz, the generics division of […] Read More

New Study Found Hydroxychloroquine Lowered COVID-19 Deaths

July 6, 2020 A study published in the International Journal of Infectious Diseases by Henry Ford Health System found that treatment with hydroxychloroquine significantly lowered the rate of deaths among patients hospitalized with COVID-19. The analysis of more than 2,500 patients across the six hospitals in the Henry Ford Health System found that 13 percent […] Read More

Hydroxycloroquine in COVID-19 Trial Restarted in UK

June 30, 2020 The British Medicines and Healthcare Products Regulatory Agency has approved the restart of a global trial that will explore whether the drugs hydroxychloroquine and chloroquine are able to prevent coronavirus infections. Led by Oxford University’s Mahidol Oxford Tropical Medicine Research Unit, the randomized, placebo-controlled trial will enroll around 40,000 healthcare workers and other at-risk workers […] Read More

Three Healthcare Organizations Issue Statement on FDA Action to End Emergency Authorization of Medications to Treat COVID-19

June 24, 2020 Joint Statement of the American Medical Association, American Pharmacists Association, and American Society of Health-System Pharmacists on new FDA action to Remove Emergency Use Authorization of Medications to Treat COVID-19 The American Medical Association, American Pharmacists Association, and American Society of Health-System Pharmacists issued a statement “emphasizing that the FDA’s recent announcement to cancel the emergency […] Read More

FDA Revoked Emergency Use Approval of Hydroxychloroquine for COVID-19

June 15, 2020 The U.S. Food and Drug Administration announced June 15 that it revoked approval called emergency use authorization (EUA) for hydroxychloroquine and chloroquine to be used to treat certain patients who had been hospitalized for COVID-19. The FDA made this decision based on its ongoing analysis of the scientific data from current studies […] Read More

Lupus and COVID-19: What You Need to Know – LIVE WEBCAST May 21 at 6 PM ET

Since the arrival of the novel coronavirus, lupus and the most prescribed drug used to treat it – hydroxychloroquine – have been thrust into the public spotlight despite the mounting scientific evidence that drug does not appear to improve clinical outcomes in patients with COVID-19. What has been talked about less is what the impact […] Read More